058820.KQ

CMG Pharmaceutical Co., Ltd. [058820.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

058820.KQ Stock Summary

Top 10 Correlated ETFs

058820.KQ


Top 10 Correlated Stocks

058820.KQ


In the News

058820.KQ Financial details

Company Rating
Neutral
Market Cap
301.4B
Income
4.05B
Revenue
93.72B
Book val./share
1324.79
Cash/share
517.49
Dividend
-
Dividend %
-
Employees
265
Optionable
No
Shortable
Yes
Earnings
18 Mar 2021
P/E
0.04
Forward P/E
-
PEG
-0
P/S
0.03
P/B
0.02
P/C
4.3
P/FCF
0.18
Quick Ratio
1.4
Current Ratio
1.53
Debt / Equity
0.13
LT Debt / Equity
0.13
-
-
EPS (TTM)
-115.95
EPS next Y
-
EPS next Q
-
EPS this Y
-113.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
76.02%
Revenue Q/Q
-7.45%
EPS Q/Q
-29.63%
-
-
-
-
SMA20
-3.64%
SMA50
-8.15%
SMA100
3.73%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
45%
ROC
0.22%
Gross Margin
41%
Oper. Margin
16%
Profit Margin
12%
Payout
-
Shs Outstand
138.89M
Shs Float
103.01M
-
-
-
-
Target Price
-
52W Range
1993.0-2830.0
52W High
-21.38%
52W Low
+11.64%
RSI
43
Rel Volume
-
Avg Volume
499.4K
Volume
Perf Week
1.14%
Perf Month
0.45%
Perf Quarter
-
Perf Half Y
-13.76%
-
-
-
-
Beta
0.737
-
-
Volatility
17.7%, 52.51%
Prev Close
2.53%
Price
2225
Change
1.37%

058820.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
173.99197.43464.1504.8635.32
Net income per share
6.3112.381.5523-3
Operating cash flow per share
22.2325.521.240.938.16
Free cash flow per share
11.9513.7-48.2812.19-41.51
Cash per share
24.231.13790.37656.4601.43
Book value per share
51.5559.481.3K1.34K1.43K
Tangible book value per share
50.7658.711.22K1.25K1.32K
Share holders equity per share
51.5559.481.3K1.34K1.43K
Interest debt per share
003.73.8652
Market cap
97.31M103.78M736.17M443.36M223.15M
Enterprise value
-152.64M-376.85M-6.82B-3.81B2.48B
P/E ratio
0.550.33.420.14-0.57
Price to sales ratio
0.020.020.010.010
POCF ratio
0.160.140.250.080.05
PFCF ratio
0.290.27-0.110.26-0.04
P/B Ratio
0.070.06000
PTB ratio
0.070.06000
EV to sales
-0.03-0.07-0.11-0.050.03
Enterprise value over EBITDA
-0.28-0.54-2.16-0.630.42
EV to operating cash flow
-0.25-0.52-2.32-0.680.5
EV to free cash flow
-0.46-0.971.02-2.27-0.46
Earnings yield
1.813.370.297.14-1.74
Free cash flow yield
3.433.74-9.113.78-24.06
Debt to equity
00000.04
Debt to assets
00000.03
Net debt to EBITDA
-0.45-0.69-2.4-0.70.39
Current ratio
1.811.6110.79.146.17
Interest coverage
0079.7480.23195.16
Income quality
3.522.0613.691.78-12.72
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.070.080.040.040.04
Research and developement to revenue
000.050.050.04
Intangibles to total assets
0.0100.060.060.07
Capex to operating cash flow
-0.46-0.46-3.28-0.7-2.09
Capex to revenue
-0.06-0.06-0.15-0.06-0.13
Capex to depreciation
-1.42-1.57-3.96-1.59-4.51
Stock based compensation to revenue
0.010.020.0100
Graham number
85.57128.69213.12833.37310.63
ROIC
0.160.2200.010
Return on tangible assets
0.080.0700.020
Graham Net
-3.21-87.2742.68599.73465.46
Working capital
364.8M405.61M132.33B111.75B113.17B
Tangible asset value
1.42B1.66B169.07B172B170.57B
Net current asset value
-9.39M-2.35B131.76B111.01B106.76B
Invested capital
00000.04
Average receivables
51.38M71.43M92.52M102.05M103.24M
Average payables
97.55M114.44M2.85B5.31B8.14B
Average inventory
20.71M23.83M7.54B14.12B17.23B
Days sales outstanding
4.685.260.590.520.47
Days payables outstanding
12.6111.4861.3751.0499.39
Days of inventory on hand
2.42.59165.18133.7188
Receivables turnover
78.0769.36616.84697.55769.06
Payables turnover
28.9531.85.957.153.67
Inventory turnover
151.89141.132.212.731.94
ROE
0.120.2100.020
Capex per share
-10.28-11.8-69.48-28.71-79.67

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
79.42781.19165.26174.37161.37
Net income per share
9.2-180.9519.4125.3618.57
Operating cash flow per share
12.5994.7-22.3810.412.11
Free cash flow per share
7.6210.97-71.849.46-9.22
Cash per share
28.042.79K636.22519.18517.49
Book value per share
83.256.63K1.35K1.31K1.32K
Tangible book value per share
82.476.11K1.22K1.18K1.2K
Share holders equity per share
83.256.63K1.35K1.31K1.32K
Interest debt per share
0240.85157.24174.66177.1
Market cap
43.87M48.12M220.06M238.73M252.17M
Enterprise value
-322.75M2.31B1B17.34B20.16B
P/E ratio
0.0400.020.020.02
Price to sales ratio
0.0200.010.010.01
POCF ratio
0.120.02-0.070.160.14
PFCF ratio
0.210.16-0.020.17-0.19
P/B Ratio
0.020000
PTB ratio
0.020000
EV to sales
-0.150.110.040.680.86
Enterprise value over EBITDA
-0.78-0.490.33.475.85
EV to operating cash flow
-0.920.87-0.3211.4411.41
EV to free cash flow
-1.527.53-0.112.57-14.98
Earnings yield
5.86-104.9112.2515.4910.74
Free cash flow yield
4.856.36-45.345.78-5.34
Debt to equity
00.040.120.130.13
Debt to assets
00.030.090.110.11
Net debt to EBITDA
-0.89-0.480.233.425.78
Current ratio
1.326.176.935.815.49
Interest coverage
0-57.6146.34118.5768
Income quality
1.37-0.52-1.150.410.65
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.060.040.030.030.03
Research and developement to revenue
00.050.040.030.01
Intangibles to total assets
00.070.070.080.08
Capex to operating cash flow
-0.4-0.882.21-0.09-1.76
Capex to revenue
-0.06-0.11-0.3-0.01-0.13
Capex to depreciation
-1.95-4.18-11.71-0.22-4.81
Stock based compensation to revenue
0.010000
Graham number
131.265.2K767.14863.49743.92
ROIC
0.11000.010
Return on tangible assets
0.04-0.030.010.020.01
Graham Net
-130.062.16K378.33250.21237.5
Working capital
259.58M113.17B126.92B114.2B106.29B
Tangible asset value
2.31B170.57B169.9B172.3B174.61B
Net current asset value
-3.41B106.76B101.3B87.53B78.96B
Invested capital
00.040.120.130.13
Average receivables
77.46M89.08M86.37M63.43M66.05M
Average payables
163.21M5.71B10.33B8.89B7.68B
Average inventory
31.6M10.65B21.8B22.32B21.24B
Days sales outstanding
2.890.440.260.220.27
Days payables outstanding
11.3191.1169.6860.1949.28
Days of inventory on hand
2.27172.34165.36160.3142.23
Receivables turnover
31.15203.91348.48417.04330.94
Payables turnover
7.960.991.291.51.83
Inventory turnover
39.570.520.540.560.63
ROE
0.11-0.030.010.020.01
Capex per share
-4.97-83.73-49.46-0.94-21.34

058820.KQ Frequently Asked Questions

What is CMG Pharmaceutical Co., Ltd. stock symbol ?

CMG Pharmaceutical Co., Ltd. is a KR stock and trading under the symbol 058820.KQ

What is CMG Pharmaceutical Co., Ltd. stock quote today ?

CMG Pharmaceutical Co., Ltd. stock price is $2225 today.

Is CMG Pharmaceutical Co., Ltd. stock public?

Yes, CMG Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar